Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / PSHS ULT NASB
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
217K
-
Shares change
-
-39.6K
-
Total reported value, excl. options
-
$22.6M
-
Value change
-
-$3.65M
-
Put/Call ratio
-
2.06
-
Number of buys
-
8
-
Number of sells
-
-13
-
Price
-
$103.99
Significant Holders of PROSHARES TR - PSHS ULT NASB (BIB) as of Q3 2014
31 filings reported holding BIB - PROSHARES TR - PSHS ULT NASB as of Q3 2014.
PROSHARES TR - PSHS ULT NASB (BIB) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 217K shares
.
Largest 10 shareholders include Valentine Capital Asset Management, Inc. (65K shares), Adamant Biomedical Investments AG (50K shares), Tower Research Capital LLC (18.5K shares), SPRINGBOK CAPITAL MANAGEMENT, LLC (17.5K shares), Citadel Advisors LLC (17.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (14.3K shares), LPL Financial LLC (8.07K shares), Verition Fund Management LLC (7.11K shares), MORGAN STANLEY (7.08K shares), and FLOW TRADERS U.S. LLC (6.37K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.